May They Receive Exactly What They Deserve; May They Meet Their Namesake Every Minute, Forever
The free market at work, ladies and gentlemen.
Cerberus Capital, one of Wall Street’s most notoriously ruthless leveraged-buyout firms (or “private equity firms” in PC-speak), recently made a $1.8 billion killing on their human plasma investment, a company called Talecris, which they bought for a mere $82.5 million just four years earlier. Meaning Cerberus made 23 times their investment on human plasma. They did it by the most savage, heartless means possible: by paying peanuts to their impoverished human plasma donors, who increasingly come from Mexican border towns to blood-pumping stations set up on the American side, jacking up the price of plasma by restricting supply (a lawsuit filed by the Federal Trade Commission accused Cerberus Plasma Holdings of “operat[ing] as an oligopoly”), and then selling the refined products to the most desperately ill, patients suffering from hemophilia, severe burns, multiple sclerosis, and autoimmune deficiencies. The products cost so much—one, IVIG (intravenous immunoglobulin) cost twice the price of gold as of last summer -- that American health insurance companies have been dropping or denying their policy holders in increasing numbers, endangering untold numbers.
I'm a woman, a Witch, a mother, a grandmother, an eco-feminist, a gardener, a reader, a writer, and a priestess of the Great Mother Earth. Hecate appears in the
Homeric Ode to Demeter, which tells of Hades who caught Persophone
"up reluctant on his golden car and bare her away lamenting. . . . But no one, either of the deathless gods or of mortal men, heard her voice, nor yet the olive-trees bearing rich fruit: only tenderhearted Hecate, bright-coiffed, the daughter of Persaeus, heard the girl from her cave . . . ."